Current and historical daily PE Ratio for EZZ Life Science Holdings Ltd (
) from 2021 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. EZZ Life Science stock (ASX:EZZ) PE ratio as of Jun 08 2024 is 13.34.
More Details
EZZ Life Science Holdings Ltd (ASX:EZZ) PE Ratio (TTM) Chart
EZZ Life Science Holdings Ltd (ASX:EZZ) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 376
- 1
- 2
- 3
- 4
- 5
| EZZ Life Science PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-08 | 13.3 | 2024-04-08 | 9.0 |
| 2024-06-07 | 13.3 | 2024-04-05 | 8.3 |
| 2024-06-06 | 13.2 | 2024-04-04 | 8.2 |
| 2024-06-05 | 12.9 | 2024-04-03 | 7.9 |
| 2024-06-04 | 12.6 | 2024-04-02 | 7.6 |
| 2024-06-03 | 12.3 | 2024-04-01 | 7.1 |
| 2024-05-31 | 13.0 | 2024-03-29 | 7.1 |
| 2024-05-30 | 11.9 | 2024-03-28 | 7.1 |
| 2024-05-29 | 11.5 | 2024-03-27 | 7.0 |
| 2024-05-28 | 12.1 | 2024-03-26 | 6.3 |
| 2024-05-27 | 12.1 | 2024-03-25 | 6.2 |
| 2024-05-24 | 12.1 | 2024-03-22 | 6.2 |
| 2024-05-23 | 12.2 | 2024-03-21 | 6.8 |
| 2024-05-22 | 12.2 | 2024-03-20 | 6.7 |
| 2024-05-21 | 11.8 | 2024-03-19 | 6.7 |
| 2024-05-20 | 11.5 | 2024-03-18 | 6.1 |
| 2024-05-17 | 10.9 | 2024-03-15 | 5.8 |
| 2024-05-16 | 12.4 | 2024-03-14 | 5.8 |
| 2024-05-15 | 13.1 | 2024-03-13 | 6.0 |
| 2024-05-14 | 12.9 | 2024-03-12 | 6.0 |
| 2024-05-13 | 11.2 | 2024-03-11 | 5.9 |
| 2024-05-10 | 10.4 | 2024-03-08 | 5.8 |
| 2024-05-09 | 10.4 | 2024-03-07 | 5.6 |
| 2024-05-08 | 10.0 | 2024-03-06 | 5.6 |
| 2024-05-07 | 10.1 | 2024-03-05 | 6.0 |
| 2024-05-06 | 9.9 | 2024-03-04 | 6.0 |
| 2024-05-03 | 10.5 | 2024-03-01 | 6.0 |
| 2024-05-02 | 9.8 | 2024-02-29 | 6.0 |
| 2024-05-01 | 10.1 | 2024-02-28 | 6.2 |
| 2024-04-30 | 10.8 | 2024-02-27 | 6.3 |
| 2024-04-29 | 10.7 | 2024-02-26 | 6.1 |
| 2024-04-26 | 11.0 | 2024-02-23 | 6.0 |
| 2024-04-25 | 10.8 | 2024-02-22 | 5.8 |
| 2024-04-24 | 10.8 | 2024-02-21 | 5.9 |
| 2024-04-23 | 10.8 | 2024-02-20 | 6.1 |
| 2024-04-22 | 10.4 | 2024-02-19 | 6.3 |
| 2024-04-19 | 10.3 | 2024-02-16 | 6.3 |
| 2024-04-18 | 10.3 | 2024-02-15 | 6.3 |
| 2024-04-17 | 10.2 | 2024-02-14 | 6.0 |
| 2024-04-16 | 10.4 | 2024-02-13 | 6.6 |
| 2024-04-15 | 10.4 | 2024-02-12 | 6.3 |
| 2024-04-12 | 10.2 | 2024-02-09 | 6.5 |
| 2024-04-11 | 9.8 | 2024-02-08 | 6.7 |
| 2024-04-10 | 9.7 | 2024-02-07 | 6.8 |
| 2024-04-09 | 9.3 | 2024-02-06 | 6.9 |
EZZ Life Science Holdings Ltd (ASX:EZZ) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
EZZ Life Science Holdings Ltd
ISIN : AU0000130569
Description
EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers